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ABSTRACT 
Fifty adult patients in Adikpo, Benue State, Nigeria having an average of 50 microfilaria/skin snip (mflss) and 2 
microfilaria/milliliter (mflml) in skin and urine respectively were given a single treatment of Ivermectin at a dose 
rate between 150 – 200mg/kg.  Five of the patients also had microfilariae in their blood.  Seven days after this 
treatment, there was a decrease of the microfilaria from pretreatment level to 17.8% and 10% in the skin and urine 
respectively (i.e.82% and 90% clearance).  There was 100% clearance in the blood.  Trace proteinuria shown in 30 
(60%) patients before treatment was increased to 45 (90%) patients after treatment.  This study has revealed that 
Ivermectin has a great efficacy in clearing microfilaria of Onchocerca volvulus in the skin, urine and blood of 
individuals.  The increase in the number of patients with mild proteinuria after treatment and its implication require 




Onchocerciasis or River blindness disease is 
caused by the infection of filarial nematode worm 
Onchocerca volvulus.  The disease affects over 80 
million people culminating in causing blindness 
with a “lion look” and visual impairment in 1 – 2 
million people in rural communities of Africa (1, 
2).  Other clinical manifestations include palpable 
onchocercal nodules (predominantly in the pelvic 
region, “Leopard skin”, elephantiasis of the 
genitalia, hanging groin and hernias (2). 
 
The disease has been reported in all parts of 
Nigeria (3) including Benue and Plateau States of 
Nigeria (4, 5, 6).  Onchocerciasis has remained 
both a significant public health and socio-economic 
problem interfering with Government plans and 
programmes.  This has especially made “Health for 
all by the year 2000” a dream rather than a reality 
(7). The importance of this disease has made it 
imperative to assess the efficacy of the “new drug” 
– Ivermectin (Mectizan) in an onchocerciasis 
endemic area of Adikpo in Benue State – Nigeria.  
Other drugs in the use before Ivermectin 
emergence have shown many adverse side effects 
beside the long periods of administration.  
Ivermectin, a microfilaricidal drug, on the other 
hand can be effective with a single treatment, it is 
safe and it has a synergistic effect on the other 
intestinal helminthes (8).  Efficacy of Ivermectin 
may have been assessed but not in Adikpo as 
literature survey has revealed. 
 
MATERIALS AND METHODS 
Ivermectin (Mectizan) were administered at a dose 
of between 150 – 200mg/mg to 50 patients that 
previously tested positive for Onchocerca volvulus 
infection by skin snip method. 20 other individuals 
that tested negative for Onchcerca volvulus 
infection were also treated with the drug at the 
same dose rate.  After seven days of the oral 
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administration of the drug, parasitological 
examination were carried out on the skin snip, 
blood (both thin and thick smear preparation of the 
peripheral blood) and urine as described by 
Anderson et al, (9).  The bloodless skin snip was 
taken from the Iliac Crest region of the body using 
a 2mm bite Holth type Corneo-scteral punch.   The 
protein in the urine was detected using the Albustix 
(AMES multiple reagent strips, Great Britain).  The 
strips were dropped into freshly voided urine which 




The mean microfilaria in the skin snips and urine 
of the 50 patients were 50mf/ss and 2mf/ml 
respectively.  The mean microfilaria after treatment 
with Ivermectin was 8.9mg/ss (17.8%) and 
0.2mf/ml (10%) in the skin and urine respectively.  
This represents an average clearance of 82.2% and 
90% from skin and urine respectively (Table 1).  
Trace proteinuria in onchocerciasis patients (n=50) 
showed that 30 (60%) of them were positive while 
20 (40%) were negative.  Those persons with no 
microfilariae in the skin serving as control were 20 
(100%).  After treatment, the proteinurial level 
increased to 45 (90%) in those positive with 
microfilariae.  The control group however 
remained negative even after the administration of 
the drug with placebo (Table 2). 
 
Table 1: Microfilariae level in skin and urine of  























































+ve (%)  -ve (%) 
 
30 (60)   20 (40) 
 






-ve (%)  
 
20 (100) 20 (100) 
 
DISCUSSION 
A rapid decrease of the skin microfilariae compare 
to the pretreatment level as noted in the present 
study has also been observed by other workers (11, 
12).  The reverse has however been the case with 
increase microfilariae in blood and urine after 
Diethyl Carbamazine (DEC) treatment (13). 
 
As in the present work, proteinuria although 
transient has been recorded in a proportion of 
Onchocerciasis patients and also among individuals 
receiving anti-filaria treatment  (10, 14, 15).  The 
number of patients with mild proteinuria agrees 
with the finding of Anderson et al, (9), who also 
reported that most Onchocerciasis patients had 
mild proteinuria (i.e. 30mg protein/100ml for those 
who do intense physical exercise).  The reason for 
mild proteinuria cannot easily be linked up with 
their occupation (farming), which is a sort of 
intense exercise since their counterparts in the 
control group showed negative proteinuria.  These 
observations may suggest some associations 
between Onchocerciasis disease and proteinuria.  
The increase in the number of cases with mild 
proteinuria after treatment may also not be linked 
up with Ivermectin, for the same reason that 
treatment with the drug in the control group 
remained unchanged.  This may need further 
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